Recent Posts

p { text-indent: 3em; }
p { text-indent: 3em; }

Author: Denise Fletcher

FEI Europe — Adapt, disrupt, innovate. This year’s FEI Europe conference in London was full of energy and ideas and I left feeling more motivated and inspired than ever to continue to find new ways to disrupt stale approaches to innovation. While every success should be celebrated, it is vital that companies don’t make the mistake of resting on their laurels. We must continue to innovate and look for new ways to think about and use technology. The good news is that there was plenty of that happening at FEI Europe.   London provided the perfect backdrop for a week of exchanging ideas at FEI Europe. The city is a unique combination of history and modernity that constantly reminds us of the importance of our past and the need to create a better future. It also didn’t hurt that I got the opportunity to meet with other thought leaders and enjoy world class...

Read More
FEI Boston Recap

FEI Boston - An Event Grounded in Remarkable People   There were over 500 people at FEI Boston 2017. I’ve been attending and speaking at FEI the last five years and noticed that this year’s attendees were from more diverse areas of responsibility.  For those who did attend you can access the presentations on line at:   Login to FEI Connect Click on the 'Presentation' tab   FEI Boston Highlights   In the next couple of weeks you will receive a link to the FEI Executive Summary. This will include key takeaways, summaries and highlights from the keynote sessions, as well as select track sessions. The goal of the executive summary is to ensure the insights you gathered at the event stay top of mind — and make them easy to distribute to your teams back at the office.   My personal favorite was hearing from Clayton Christensen around the job to be done. Having been in Innovation for...

Read More

Pharmaceutical Accelerate Innovation with Software Technology   First, A Look at Deloitte's US Life Sciences Outlook Report   Deloitte released the 2017 US Life Sciences Outlook and the report discusses some very important points for the pharmaceutical sector to consider. It’s a great report and one worth reading. Let’s compound this with a few other events occurring in this space: The healthcare bill on the senate floor that’s yet to be determined. The more informed consumers that think nothing of taking to social media to complain about the cost of care and drug prices. The press and evening news reporting immediately on the fallout from social media and drug prices. High deductible plans continue to trend upwards which equates to more consumers paying more out of their wallet for healthcare. And then there's Amazon...

Read More